Skip to main content
International Journal of Critical Illness and Injury Science logoLink to International Journal of Critical Illness and Injury Science
. 2020 Mar 6;10(1):16–19. doi: 10.4103/IJCIIS.IJCIIS_83_19

Cervical spinal stenosis and risk of pulmonary dysfunction

Esraa M Fahad 1,, Zainab M Hashm 1, Ihsan M Nema 1
PMCID: PMC7170349  PMID: 32322549

Abstract

Background:

Cervical spinal stenosis (CSS) is defined as an abnormal narrowing of the cervical spinal canal. The essential clinical challenges with CSS are altered cervical spinal cord function and cervical radiculopathy. Phrenic nerve palsy leading to hemidiaphragmatic paresis may be a temporary or persistent phenomenon after cervical cord injury and CSS.

Objective:

The objective of the study is to elucidate the potential effect of CSS on the pulmonary functions.

Methods:

This is a case–control study which included 40 patients divided into two groups 30 females and 10 males patients with CSS (C5 and above) and 60 healthy volunteers with body mass index (BMI) <30 Kg/m2. Pulmonary function tests have been done for all the patients.

Results:

The present study showed that VC in expiration (VC EX%), forced expiratory volume (FEV%), forced vital capacity % (FVC%), PEF%, and mean voluntary ventilation % (MVV%), were low in patients CSS compared with the control groups; P < 0.001, P < 0.001, P < 0.001, P = 0.042, and P = 0.037, respectively. As well, VC EX%, FEV1%, and FVC% were low in male patients in comparison to the controls P < 0.05. Besides, there were no significant differences regarding age, BMI, VC in inspiration (VC IN%), PEF%, FEV1/FVC%, and MVV%. Moreover, VC EX%, FEV1%, and FVC% were low in female patients compared to the controls, P < 0.001. Whereas, there were no significant differences that had been identified between female patients and female controls regarding age, BMI, VC IN%, PEF%, FEV1/FVC%, and MVV%. On the other hand, weight, height, and MVV% were low in female patients compared to male patients, P < 0.001.

Conclusion:

Chronic CSS leads to subclinical pulmonary dysfunction due to the involvement of the phrenic nerve. FEV% is the most sensitive parameter in the detection these disorders.

Key Words: Cervical spinal stenosis, pulmonary function tests, spirometry

INTRODUCTION

Cervical spinal stenosis (CSS) is defined as an abnormal narrowing of the cervical spinal canal.[1] The essential clinical challenges with CSS are altered cervical spinal cord function and cervical radiculopathy. Narrowing of the cervical spinal canal may be unassociated with a separate pathologic process affecting the spinal cord or other portions of the nervous system.[2] CSS can result from any process that narrows the canal. It can be congenital and usually produces no clinical disease in childhood. When degenerative conditions of the spine are superimposed on congenital stenosis, the adults may begin to show symptoms or signs of degenerative spine disease prematurely in the age of 30–40 years.[3] The abnormal cord signal should be juxtaposed to the stenotic segment and not at a different cervical spine level in order to be postulated as related to the spinal stenosis. The prognosis of CSS depends on the function of the patient at the time of diagnosis and the underlying etiology.[4,5]

Usually, pulmonary function and respiratory muscles movement are under control of phrenic nerve (C3-C5), intercostal nerves (T2-T10), and sympathetic neurons (T1-L3). The diaphragm is the most important inspiratory muscle, accounting for 75% of the increase in lung volume during quiet inspiration; intercostal, scalene, and sternocleidomastoid muscles contribute the remaining 25%.[6] There is little crossover innervation of the right and left hemidiaphragms, and each can contract independently of the other in the event of unilateral phrenic nerve palsy. In the presence of diaphragmatic paresis, inspiration is achieved largely by contraction of intercostal and accessory muscles and expansion of the rib cage.[7]

Phrenic nerve palsy leading to hemidiaphragmatic paresis may be a temporary or persistent phenomenon after cervical cord injury and CSS. Transient phrenic nerve palsy appears to have little clinical significance in terms of both objective (respiratory support) and subjective (dyspnea) features. Persistent phrenic nerve palsy is common after acute cervical cord injury which may lead to acute pulmonary dysfunction.[8]

Electrophysiologic studies have been conducted on patients with cervical cord stenosis, specifically addressing the phrenic nerve. Muscle action potentials (MAPs) from the diaphragm as an indirect assessment of spinal cord dysfunction. The phrenic nucleus resides in the ventral gray horn from C3 to C5 of the spinal cord. CMAP is elicited from transcranial electrical stimulation of the motor cortex in patients with high cervical myelopathy.[9]

Therefore, the aim of the present study was to elucidate the potential effect of CSS on the pulmonary functions.

METHODS

This is case–control, randomized, single-center study involved forty patients (30 females + 10 males) with cervical spine stenosis compared with sixty healthy individuals. The patients were recruited from the Consultant Unite of Department of Neurosurgery in cooperation with Department of Orthopedic of AL-Imamian AL-Kadhymiyian Medical City during the period from November 2018 to May 2019, Baghdad Iraq. The recruited patients were aged 25–70 years, body mass index (BMI) <30 Kg/m2 with duration of their disease ranged 1–24 months. The study was approved by the Institutional Review Board of the College of Medicine, Al-Nahrain University, and informed consent was obtained from all the participants.

All patients were clinically examined and diagnosed by magnetic resonance imaging and other radiological diagnostic tools such as computing tomography scanning and X-ray of the cervical spine to determine the level of cervical cord compression. The diagnosis was supported by transcranial magnetic stimulation technique.

Inclusion criteria

Any patients with cervical canal stenosis with duration of 1–24 months with or without pulmonary dysfunctions were included in the study.

Exclusion criteria

Obesity, chronic smoking, obstructive airway diseases, restrictive airway diseases, malignancy, congenital spinal stenosis, peripheral neuropathy, diabetes mellitus, metabolic diseases, psychiatric, and mental disorders were excluded from the study.

Assessment of pulmonary functions

Vital capacity (VC%) in inspiration (VC IN), VC in expiration (VC EX), forced expiratory volume (FEV1), forced VC (FVC), forced expiratory flow FVC, Peak expiratory flow rate PEFR and mean voluntary ventilation (MVV), and ratio of FEV1 to FVC (FEV1/FVC) were estimated by spirometry (spy-ROM-uh-tree, USA). All predicted values of the spirometric parameters were based on the patient's height, age, and sex. The percentage of predicted values were used for comparison of the results (% predicted = measured ÷ predicted)[10]

Statistical analysis

Data presented as mean ± standard deviation and unpaired Student's t-test was used to determine the significance of differences. Data analysis was done using SPSS (IBM SPSS Statistics for Windows version 20.0, 2014, IBM, Corp., Armonk, NY, USA). P < 0.05 was considered statistically significant.

RESULTS

The present study showed that VC EX%, FEV1%, FVC%, PEF%, and MVV%, were low in patients CSS compared with the control groups P < 0.001, P < 0.001, P < 0.001, P = 0.042, and P = 0.037, respectively. While, there were no significant differences that had been identified between patients and controls regarding age, weight, height, BMI, VC IN%, and FEV1/FVC%, Table 1.

Table 1.

Comparison of data between all patients and all controls by unpaired t-test

Parameter Mean±SD
P
All patients (n=40) All controls (n=60)
Age (years) 50.05±12.5 49.92±11.04 0.955
Weight (kg) 67.05±8.04 70.42±9.36 0.066
Height (cm) 159.93±8.99 162.28±9.49 0.217
BMI (kg/m2) 26.21±2.29 26.71±2.29 0.282
VC IN (%) 90.48±14.35 94.33±13.58 0.177
VC EX (%) 79.23±11.24 90.86±11.8 <0.001
FEV1 (%) 89.16±15.59 105.53±14.04 <0.001
FVC (%) 77.26±13.1 90.56±12.69 <0.001
PEF (%) 85.21±14.82 93.21±21.32 0.042
FEV1/FVC (%) 95.72±4.08 96.56±3.89 0.302
MVV (%) 98.42±16.77 106.14±18.55 0.037

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

As well, VC EX%, FEV1%, and FVC% were low in male patients in comparison to the controls, P < 0.05. Besides, there were no significant differences regarding age, BMI, VC IN%, PEF%, FEV1/FVC%, and MVV% [Table 2].

Table 2.

Comparison of data between male patients and male controls by unpaired t-test

Parameter Mean±SD
P
Male patients (n=10) Male controls (n=30)
Age (years) 55.5±12.07 52.9±11.38 0.541
Weight (kg) 75.0±6.38 73.87±10.46 0.749
Height (cm) 170.5±5.97 168.4±7.89 0.446
BMI (kg/m2) 25.78±1.44 25.94±2.43 0.850
VC IN (%) 84.7±14.11 89.94±12.36 0.269
VC EX (%) 74.71±7.51 88.32±11.71 0.001
FEV1 (%) 88.18±12.5 105.81±16.36 0.004
FVC (%) 73.51±9.75 88.9±13.08 0.002
PEF (%) 89.59±14.02 92.1±16.41 0.667
FEV1\FVC (%) 95.36±3.11 95.9±4.33 0.715
MVV (%) 119.11±11.67 119.2±15.24 0.987

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

Moreover, VC EX%, FEV1%, and FVC% were low in female patients compared to the controls P < 0.001. Whereas, there were no significant differences that had been identified between female patients and female controls regarding age, BMI, VC IN%, PEF%, FEV1/FVC%, and MVV% [Table 3].

Table 3.

Comparison of data between female patients and female controls by unpaired t-test (n=30)

Parameter Mean±SD
P
Female patients Female controls
Age (years) 48.23±12.3 46.93±10 0.655
Weight (kg) 64.4±6.73 66.97±6.65 0.143
Height (cm) 156.4±6.8 156.17±6.59 0.893
BMI (kg/m2) 26.35±2.52 27.48±1.86 0.051
VC IN (%) 92.4±14.14 98.73±13.49 0.082
VC EX (%) 80.74±11.96 93.4±11.53 <0.001
FEV1 (%) 89.48±16.67 105.25±11.54 <0.001
FVC (%) 78.5±13.96 92.21±12.29 <0.001
PEF (%) 83.74±15.02 94.32±25.55 0.056
FEV1\FVC (%) 95.84±4.39 97.22±3.33 0.177
MVV (%) 91.52±11.79 93.08±10.72 0.594

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

On the other hand, weight, height, and MVV% were low in female patients compared to male patients, P< 0.001 [Table 4].

Table 4.

Comparison of data between male and female patients by unpaired t-test

Parameter Mean±SD
P
Male patients (n=10) Female patients (n=30)
Age (years) 55.5±12.07 48.23±12.3 0.112
Weight (kg) 75.0±6.38 64.4±6.73 <0.001
Height (cm) 170.5±5.97 156.4±6.8 <0.001
BMI (kg/m2) 25.78±1.44 26.35±2.52 0.507
VC IN (%) 84.7±14.11 92.4±14.14 0.144
VC EX (%) 74.71±7.51 80.74±11.96 0.144
FEV1 (%) 88.18±12.5 89.48±16.67 0.823
FVC (%) 73.51±9.75 78.5±13.96 0.303
PEF (%) 89.59±14.02 83.74±15.02 0.286
FEV1\FVC (%) 95.36±3.11 95.84±4.39 0.747
MVV (%) 119.11±11.67 91.52±11.79 <0.001

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

DISCUSSION

The present study illustrated insignificant differences in the anthropometric variables in patients with CSS compared to the control as revealed by Toyoda et al.[11] Besides, the findings of the present study showed that VC%, FVC%, PEF%, FEV1%, and MVV% of patients with CSS were low compared to the controls. It has been reported that dysfunctional breathing is the main cause of morbidity and mortality after traumatic injury of the cervical spinal cord and often necessitates assisted ventilation, thus stressing the need to develop strategies to restore breathing. Cervical interneurons that form synapses on phrenic motor neurons, which control the main inspiratory muscle, can modulate phrenic motor output and diaphragmatic function.[12] Therefore, patients with compressive CSS lead to the impairment of respiratory function.[13] Indeed, CSS leads to weakness of diaphragm and intercostal muscles due to partial injury to the phrenic nerve and cervical nerves, respectively, as well as noteworthy reduction of sympathetic neurons activity.[14] The extent of respiratory complications depends on the level of spinal stenosis, and the degree of motor impairment as VC and forced expired volume (FEV1) were normal in patients with low-level paraplegia.[15] In the present study, there was no significant difference between FEV1/FVC% of patients with CSS which might due to subclinical myelopathy in the affect patients since; Aljuboori and Boakya confirmed that only advanced CSS leads to autonomic and respiratory dysfunctions.[16] On the other hand, MVV% was significantly low in females in comparison to males' patients. This is in accordance with the study done by Budhiraja et al.; this can be attributed to the fact that the men have bigger lungs for the same height as compared to females. Another contributing factor could be the greater strength of respiratory muscles in males.[17]

Furthermore, this study confirmed that FEV1% was high specific and sensitive among other parameters of spirometry in patients with CSS since; the classification of the severity of obstructive and restrictive pulmonary impairments based on the grade of reduction in FEV1.[18] Otherwise, the categorizing of restrictive impairment stated by the European Respiratory Society in 2005 has been established based on predicted FEV1%.[19]

Therefore, various recommendations are reported about the management of respiratory complications associated with CSS. They include positioning and postural changes, breathing techniques, spontaneous cough and cough assistance, suctioning, respiratory muscle training, ventilation techniques and education, vaccination agents for influenza and pneumococcal infections, and pharmacological interventions. Furthermore, the modifiable risk factors must be addressed, particularly in patients with acute but not in CSS.[20]

CONCLUSION

Chronic CSS leads to subclinical pulmonary dysfunction due to the involvement of the phrenic nerve. FEV% is the most sensitive parameter in the detection of these disorders.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Ethical conduct of research

This study was approved by the Institutional Review Board / Ethics Committee. The authors followed applicable EQUATOR Network (http://www.equator-network.org/) guidelines during the conduct of this research project.

Acknowledgment

The authors would like to express deep thanks for all enrolled patients and volunteers.

REFERENCES

  • 1.Lebl DR, Bono CM. Update on the diagnosis and management of cervical spondylotic myelopathy. J Am Acad Orthop Surg. 2015;23:648–60. doi: 10.5435/JAAOS-D-14-00250. [DOI] [PubMed] [Google Scholar]
  • 2.Al-Kuraishy HM, Al-Gareeb AI, Hussien NR, Al-Naimi MS, Rasheed HA. Statins an oft-prescribed drug is implicated in peripheral neuropathy: The time to know more. JPMA. The Journal of the Pakistan Medical Association. 2019;69:S108–12. [PubMed] [Google Scholar]
  • 3.Li J, Jiang DJ, Wang XW, Yuan W, Liang L, Wang ZC. Mid-term outcomes of anterior cervical fusion for cervical spondylosis with sympathetic symptoms. Clin Spine Surg. 2016;29:255–60. doi: 10.1097/BSD.0b013e31827b4cec. [DOI] [PubMed] [Google Scholar]
  • 4.Al-kuraishy HM. Molecular Microbiology and Statins Frontier. J Mol Microbiol. 2017;1:e102. [Google Scholar]
  • 5.Al-Kuraishy HM, Al-Gareeb AI. Co-administration effects of α-lipoic acid and nucleo CMP on arousal and sensory cortical activity. Journal of Young Pharmacists. 2016;8:12–7. [Google Scholar]
  • 6.Cilekar S, Tülek B, Kanat F, Süerdem M, Levendoglu F, Taşpınar IT. Effect of low-intensity pulmonary rehabilitation program on quality of life and pulmonary functions in patients with stable chronic obstructive pulmonary disease. Eurasian J Pulmonol. 2019;21:14. [Google Scholar]
  • 7.Dahl AB, Neal JM, Mulroy MF. Hemidiaphragmatic paresis associated with brachial plexus blockade: A common adverse effect masquerading as cardiopulmonary disease. Am J Emerg Med. 2016;34:1733.e5–7. doi: 10.1016/j.ajem.2015.12.053. [DOI] [PubMed] [Google Scholar]
  • 8.Greene CL, Mainwaring RD, Sidell D, Yarlagadda VV, Patrick WL, Hanley FL. Impact of phrenic nerve palsy and need for diaphragm plication following surgery for pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals. Semin Thorac Cardiovasc Surg. 2018;30:318–24. doi: 10.1053/j.semtcvs.2018.03.004. [DOI] [PubMed] [Google Scholar]
  • 9.Noda Y, Sekiguchi K, Kohara N, Kanda F, Toda T. Ultrasonographic diaphragm thickness correlates with compound muscle action potential amplitude and forced vital capacity. Muscle Nerve. 2016;53:522–7. doi: 10.1002/mus.24902. [DOI] [PubMed] [Google Scholar]
  • 10.Bland RD, Shoemaker WC. Common physiologic patterns in general surgical patients: Hemodynamic and oxygen transport changes during and after operation in patients with and without associated medical problems. Surg Clin North Am. 1985;65:793–809. doi: 10.1016/s0039-6109(16)43682-0. [DOI] [PubMed] [Google Scholar]
  • 11.Toyoda H, Nakamura H, Konishi S, Terai H, Takaoka K. Does chronic cervical myelopathy affect respiratory function? J Neurosurg Spine. 2004;1:175–8. doi: 10.3171/spi.2004.1.2.0175. [DOI] [PubMed] [Google Scholar]
  • 12.Satkunendrarajah K, Karadimas SK, Laliberte AM, Montandon G, Fehlings MG. Cervical excitatory neurons sustain breathing after spinal cord injury. Nature. 2018;562:419–22. doi: 10.1038/s41586-018-0595-z. [DOI] [PubMed] [Google Scholar]
  • 13.Nishida T, Ishiguro T, Ota C, Takaku Y, Kagiyama N, Kurashima K, et al. Restrictive ventilatory impairment improved by laminoplasty for ossification of the posterior longitudinal ligament. Clin Case Rep. 2019;7:284–8. doi: 10.1002/ccr3.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Massetti J, Stein DM. Neurocritical Care for the Advanced Practice Clinician. Cham: Springer; 2018. Spinal cord injury; pp. 269–88. [Google Scholar]
  • 15.Berlowitz DJ, Wadsworth B, Ross J. Respiratory problems and management in people with spinal cord injury. Breathe (Sheff) 2016;12:328–40. doi: 10.1183/20734735.012616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Aljuboori Z, Boakye M. The natural history of cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament: A review article. Cureus. 2019;11:e5074. doi: 10.7759/cureus.5074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Budhiraja S, Singh D, Pooni PA, Dhooria GS. Pulmonary functions in normal school children in the age group of 6-15 years in North India. Iran J Pediatr. 2010;20:82–90. [PMC free article] [PubMed] [Google Scholar]
  • 18.Do KH, Choi EJ, Chang MC, Yang HE. Hypercapnia caused by a therapeutic dosage of pregabalin in a tetraplegic patient with cervical spinal cord injury. Am J Phys Med Rehabil. 2017;96:e223–e226. doi: 10.1097/PHM.0000000000000735. [DOI] [PubMed] [Google Scholar]
  • 19.Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68. doi: 10.1183/09031936.05.00035205. [DOI] [PubMed] [Google Scholar]
  • 20.Hart JE, Morse L, Tun CG, Brown R, Garshick E. Cross-sectional associations of pulmonary function with systemic inflammation and oxidative stress in individuals with chronic spinal cord injury. J Spinal Cord Med. 2016;39:344–52. doi: 10.1179/2045772315Y.0000000045. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Critical Illness and Injury Science are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES